Combination gene therapy for salivary gland cancer

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 163-170

  O'Malley Jr , Bert W ^a   Li, Daqing ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GANCICLOVIR; INTERLEUKIN 2; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; SALIVARY GLAND CANCER; SQUAMOUS CELL CARCINOMA; SUBMANDIBULAR GLAND; TUMOR REGRESSION; VIRUS RECOMBINANT;

EID: 0031959412     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09644.x     Document Type: Conference Paper

References (17)

1. KAPLAN, M.J. & M.E. JOHNS. 1993. Salivary Glands: Malignant neoplasms. In Otolaryngology-Head and Neck Surgery, second edition. Mosby-Year Book, Inc. St. Louis, Missouri.
2. FRIEDMAN, M. et al. 1986. Malignant tumors of the major salivary glands. Otolaryngol. Clin. North. Am. 19: 625-630.
3. FEARON, E.R., D.M. PARDOLL, R. ITAYA, P. GOLUMDEK, H. LEVITSKY & J. SIMONS. 1990. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397-403.
4. DRANOFF, G., E. JAFFEE, A. LAZENBY, P. GOLUMBEK, H. LEVITSKY, K. BROSE, V. JACKSON, H. HIROFUMI, D.M. PARDOLL & R.C. MULLIGAN. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stim-ulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90: 3539-3543.
5. GANSBACJER, B., K. ZIER, B. DANIELS, K. CRONIN, R. BANNERJI & E. GILBOA. 1990. Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172: 1217-1224.
6. MOOLTEN, F.L. 1986. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer. Res. 46: 5276-5281.
7. MOOLTEN, F.L. & J.M. WELLS. 1990. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82: 297-300.
8. O'MALLEY, B.W. JR., S.-H. CHEN, M.R. SCIIWARTZ & S.L.C. Woo. 1995. Adenovirusmediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 55: 1080-1085.
9. O'MALLEY, B.W. JR, K.A. COPE, S.-H. CHEN, D. Li, M.R. SCHWARTZ & S.L.C. Woo. 1996. Combination gene therapy for oral cancer in a murine model. Cancer Res. 56: 1737-1741.
10. CHEN, S.-H., D. SHINE, J.C. GOODMAN, R.G. GROSSMAN & S.L.C. Woo. 1994. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91: 3054-3057.
11. GRANDIS, J.R., M.-J. CHANG, W.-D. Yu &C.S. JOHNSON. 1995. Antitumor activity of interleukin-1a and Cisplatin in a murine model system. Arch. Otolaryngol. Head & Neck Surg. 121: 197-200.
12. O'MALLEY, B.W. JR., K.A. COPE, C.S. JOHNSON & M.R. SCHWARTZ. 1997. A new immunocompetent murine model for oral cancer. Arch. Otolaryngol. Head Neck Surg. 123: 20-24.
13. ROTH, J.A. & R.J. CRISTIANO. 1997. Gene therapy for cancer: What have we done and where are we going? J. Natl. Cancer. Inst. 89(1): 21-39.
14. CHEN, S-H., X.H. Li CHEN, Y. WANG, K.-I. KOSAI, M.J. FINEGOLD, S.S. RICH & S.L.C. Woo. 1995. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92: 2577-2581.
15. WAN, L.B., L.M. PARYSEK, R. WARNICK & P.J. STAMBROOK. 1993. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Then 4: 725-731.
16. FREEMAN, S.M., C.N. ABBOUD, K.A. WHARTENBY, D.S. KOEPLIN, F.L. MOOLTEN & G.N. ABRAHAM. 1993. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53: 5274-5283.
17. Yu, G.Y. & D.Q. MA. 1987. Carcinoma of the salivary gland: A clinicopathologic study of 405 cases. Semin. Surg. Oncol. 3: 240-244.